Second-degree atrioventricular (AV) block represents a critical disruption in the electrical conduction system of the heart, where impulses from the atria fail to consistently reach the ventricles. This condition sits between the benign irregularity of first-degree block and the life-threatening complete heart block, demanding careful evaluation and precise management. Understanding the nuances of this conduction abnormality is essential for clinicians to prevent progression and mitigate potential hemodynamic compromise.
Physiological Mechanisms and Classification
The heart's electrical signal originates in the sinoatrial node, travels through the atrioventricular node, and proceeds to the bundle of His and Purkinje fibers to coordinate ventricular contraction. In second-degree AV block, this transmission is partially impaired. The classification hinges on the specific site of the block and the pattern of failure, distinguishing between two primary types based on the morphology of the ECG tracing.
Mobitz Type I: The Wenckebach Phenomenon
Mobitz Type I, also known as Wenckebach, is characterized by a progressive lengthening of the PR interval on the ECG until a beat is eventually dropped. This cyclical pattern occurs because the AV node has a decremental conduction property, where repeated impulses lead to increased fatigue and eventual failure. Typically, this block is located within the node itself and is often transient, associated with factors like increased vagal tone, medications, or acute inferior myocardial infarction. While it can cause symptoms like dizziness, it is generally considered less dangerous than its counterpart.
Mobitz Type II: A Serious Conduction Defect
Mobitz Type II presents a more ominous clinical picture, where the PR interval remains constant and normal on the ECG before a sudden, unpredictable drop of a QRS complex. This indicates a block distal to the AV node, often within the bundle branches or fascicles. Unlike Type I, this defect does not typically involve the AV node's fatigable pathways. The primary concern with Mobitz Type II is its high risk of progression to complete heart block, which can lead to severe bradycardia, syncope, or sudden cardiac arrest, necessitating urgent intervention.
Clinical Evaluation and Diagnostic Approach
Diagnosis begins with a thorough clinical assessment, focusing on symptoms such as syncope, presyncope, fatigue, or signs of heart failure. The cornerstone of diagnosis is the 12-lead ECG, which must be analyzed meticulously to identify the specific type of block and its location. Continuous cardiac monitoring, such as Holter monitoring or telemetry, is crucial to determine the frequency and severity of the dropped beats, as intermittent block can be easily missed on a single ECG strip.
Management Strategies and Treatment Indications Management is dictated by the type, symptoms, and underlying cause. Asymptomatic Mobitz Type I often requires only observation and review of medications. In contrast, symptomatic second-degree AV block, particularly Mobitz Type II, frequently warrants pacemaker implantation to prevent progression to complete heart block. Temporary transvenous pacing is indicated in acute settings with significant bradycardia or instability, while addressing reversible causes such as electrolyte imbalances or drug toxicity is a critical component of care. Prognosis and Long-Term Considerations
Management is dictated by the type, symptoms, and underlying cause. Asymptomatic Mobitz Type I often requires only observation and review of medications. In contrast, symptomatic second-degree AV block, particularly Mobitz Type II, frequently warrants pacemaker implantation to prevent progression to complete heart block. Temporary transvenous pacing is indicated in acute settings with significant bradycardia or instability, while addressing reversible causes such as electrolyte imbalances or drug toxicity is a critical component of care.
The prognosis varies significantly based on the type and etiology. Wenckebach physiology arising from an acute myocardial infarction may resolve as the infarction heals, whereas Mobitz Type II often signifies irreversible structural disease within the conduction system. Patients with underlying structural heart disease, such as cardiomyopathy or valvular disorders, face a higher risk of complications. Long-term follow-up with cardiology is essential to monitor device function if a pacemaker is placed and to manage any evolving cardiac conditions.
